ALPS Advisors’s Omega Protein OME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-29,042
Closed -$484K 904
2017
Q3
$484K Buy
29,042
+4,423
+18% +$71.9K ﹤0.01% 584
2017
Q2
$441K Buy
24,619
+63
+0.3% +$1.18K ﹤0.01% 625
2017
Q1
$492K Buy
24,556
+7,585
+45% +$177K ﹤0.01% 464
2016
Q4
$425K Buy
16,971
+161
+1% +$3.8K ﹤0.01% 546
2016
Q3
$393K Sell
16,810
-4,463
-21% -$105K ﹤0.01% 617
2016
Q2
$425K Sell
21,273
-1,561
-7% -$29.1K ﹤0.01% 392
2016
Q1
$387K Sell
22,834
-8,598
-27% -$176K ﹤0.01% 567
2015
Q4
$698K Hold
31,432
0.01% 240
2015
Q3
$5.33K Buy
+31,432
New +$489K 0.01% 285
2015
Q1
Sell
-35,910
Closed -$380K 794
2014
Q4
$380K Sell
35,910
-4,790
-12% -$56.7K ﹤0.01% 542
2014
Q3
$509K Buy
+40,700
New +$567K ﹤0.01% 563

ALPS Advisors's OME Position: Q4 2017 in Review

ALPS Advisors sold out of Omega Protein (OME) in Q4 2017, closing a stake of 29,042 shares — an estimated $484K sold.

ALPS Advisors first reported a position in OME in Q3 2014 and held it in 11 quarters. The position peaked at $698K in Q4 2015. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.

  • ALPS Advisors reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
  • ALPS Advisors sold 29,042 Omega Protein shares in Q4 2017, an estimated $484K.
  • ALPS Advisors first reported a position in Omega Protein in Q3 2014 and held it in 11 quarters.
  • ALPS Advisors's Omega Protein position peaked at $698K in Q4 2015.
  • 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.

Based on ALPS Advisors's 13F filing for Q4 2017, filed 5 Feb 2018.